HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Léa Nadège Bonkian Selected Research

Amodiaquine (Camoquin)

1/2020In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Léa Nadège Bonkian Research Topics

Disease

3Malaria
01/2020 - 01/2017
1Falciparum Malaria (Plasmodium falciparum Malaria)
01/2020

Drug/Important Bio-Agent (IBA)

2artemisinin (artemisinine)IBA
01/2020 - 01/2018
1Lumefantrine Drug Combination Artemether (Coartem)FDA Link
01/2020
1Amodiaquine (Camoquin)FDA Link
01/2020
1ArtesunateIBA
01/2020
11,12- bis(4- methyl- 5- (2- hydroxyethyl)thiazol- 3- ium- 3- yl)dodecaneIBA
01/2017
1Choline (Choline Chloride)IBA
01/2017

Therapy/Procedure

3Therapeutics
01/2020 - 01/2017
1Chemoprevention
01/2020
1Mass Drug Administration
01/2020